Schedule Policy/Career Reclassifies Federal Grant-Makers: What 50,000 At-Will Program Officers Mean for Your NSF, NIH, and DoD Proposals

The Office of Personnel Management's final rule implementing Schedule Policy/Career — the renamed and reissued version of the 2020 Schedule F executive order — took effect in March 2026, and the implications for the federal grant-making workforce are now coming into focus. The rule reclassifies federal employees in positions deemed to involve "policy-influencing work" into a new category that strips them of due process protections, Merit Systems Protection Board appeal rights, and most whistleblower safeguards.

OPM estimates 50,000 federal workers across government could be affected. The Association of American Medical Colleges has publicly suggested the number could be four times that. And among the positions OPM has explicitly identified as eligible for transfer are grant reviewers, program officers, advisory council members, and agency leadership in science funding roles at the National Institutes of Health, the National Science Foundation, and the Department of Defense.

For grant seekers, this is not an abstract civil service controversy. It is a structural change to the people on the other side of every grant decision — and the relationships, norms, and behaviors that grant strategy has rested on for four decades. This deep dive explains what changed, what hasn't, and how proposal teams should adapt their approach in 2026 and beyond.

What the Rule Actually Does

Schedule Policy/Career — formally established by OPM's "Restoring Accountability to Policy-Influencing Positions" rule — creates a federal employment category that sits between traditional career civil service (Title 5 competitive service) and political appointees. Workers placed in the new schedule:

• Lose Title 5 removal protections. They become at-will employees subject to termination without the procedural protections that have governed civil service since the Pendleton Act of 1883.
• Lose Merit Systems Protection Board appeal rights for adverse personnel actions.
• Lose access to the Office of Special Counsel for whistleblower complaints. Such complaints would instead be routed to the employing agency's general counsel.
• Are not political appointees. They remain career employees in name, can be hired through competitive processes, and retain pay scale protections — but the foundational firing protections are gone.

OPM stated in the rule that 94% of the 40,500 public comments received during the comment period opposed the policy. The agency proceeded anyway, citing the President's constitutional authority over the executive branch workforce.

Why Grant-Making Roles Are in the Crosshairs

OPM's rationale for including science funding positions rests on a specific legal claim: that program officers and senior reviewers exercise "policy-influencing" discretion when deciding which proposals to fund. The agency wrote in response to public comments that "some positions in scientific grantmaking influence public policy."

This framing is contested. The traditional view — held by research universities, professional societies, and the agencies themselves until recently — is that program officers exercise technical and scientific judgment, applying merit review principles to proposals within a defined funding portfolio. The new framing treats those same decisions as policy-making.

The practical question of which specific positions get converted is opaque. OPM stated that "agencies have already recommended positions to convert," but no agency-by-agency reclassification list has been published. NIH, NSF, and the Department of Defense declined to comment on their plans when asked by reporters.

What is publicly known:

• Advisory council members at NIH (the National Advisory Councils that approve grant awards at each institute) are explicitly named as eligible for transfer.
• Program officers — the staff who manage portfolios, communicate with applicants, and recommend funding decisions — are explicitly named as eligible.
• Grant reviewers — including study section members and scientific review officers — are explicitly named as eligible. Note this is distinct from the volunteer external peer reviewers who serve on study sections, but does include the federal scientific review officers who manage them.
• Senior agency leadership including institute directors and center directors are eligible.

The administration has not publicly committed to converting every eligible position, and OPM has stated it expects "relatively few" technical and scientific positions will actually be moved. But the legal authority to move them now exists, and the legal challenges currently pending may not resolve for years.

What Grant Seekers Should Actually Do

The strategic implications fall into four categories. None of them require panicking. All of them require updating practices that worked under the prior regime.

1. Document Every Material Interaction in Writing

The most reliable historical defense against arbitrary program officer decisions has been the institutional memory of long-tenured federal staff and the procedural paper trail that civil service protections enforce. When a program officer encouraged a resubmission, suggested specific revisions, or signaled funding likelihood, that informal communication shaped applicant behavior — and was protected by the implicit norm that the program officer would still be there next year.

In an at-will environment, that assumption weakens. Program officers may turn over more frequently. Verbal commitments and informal guidance become harder to enforce. Grant teams should:

• Confirm material program officer guidance in writing (email, then save). "Thank you for our call today. To confirm, you suggested that we strengthen Aim 2 with preliminary data on X and consider a resubmission in the September cycle."
• Save all written correspondence from federal staff in a centralized, organization-controlled repository — not just individual PI inboxes.
• Note program officer names and dates in the grant management system so that turnover doesn't erase institutional context.

2. Avoid Sole-Source Program Officer Relationships

In the traditional grant ecosystem, building a relationship with a specific program officer over years was the dominant strategy. That officer learned your work, advocated internally, and remembered your prior submissions. The investment paid off over multiple cycles.

If program officers turn over more frequently — either through firings or through preemptive departures by employees who decline to work under reduced protections — the return on that investment shrinks. Diversification becomes more important:

• Identify two or three potential program officers within an agency or institute whose portfolios fit your work, not one.
• Engage with study section chairs, scientific review officers, and division directors in addition to assigned program officers.
• Cultivate relationships at the institute or division level rather than purely individually.

3. Watch for Politically Sensitive Topic Areas

OPM's rationale rests on the claim that grant-making influences policy. The corollary is that grant areas perceived as politically sensitive — climate change, environmental justice, vaccine research, sexual and gender minority health, social determinants of health, certain education research areas — face greater risk of either funding-decision pressure or post-award scrutiny.

Recent grant cancellations at the National Endowment for the Humanities — ruled unconstitutional by a district court that was sharply critical of DOGE's use of AI in cancellation decisions — illustrate the pattern. The NEH terminations didn't happen because of Schedule Policy/Career; they happened under different legal authority. But the workforce reclassification removes a structural check on similar patterns at NIH and NSF.

Proposal teams working in sensitive areas should:

• Frame research questions in terms that are technically precise rather than politically charged where possible without distorting the science.
• Build broader stakeholder coalitions before submission — research partners, professional societies, community organizations — that can provide political cover post-award.
• Have a documented contingency plan for post-award policy changes, including documentation requirements that would support legal challenges to any termination.

4. Engage With Pending Litigation Through Professional Societies

A coalition of federal employee unions, Citizens for Responsibility and Ethics in Washington, Democracy Forward, and Public Employees for Environmental Responsibility have sued to block the policy on constitutional and statutory grounds. Multiple research-focused organizations have filed amicus briefs supporting the challenge. The eventual outcome — likely years away through appellate review — will determine whether Schedule Policy/Career persists or is enjoined.

Individual researchers cannot meaningfully participate in this litigation. But professional societies (AAMC, AAAS, FASEB, the American Association of Universities, NACAC, and discipline-specific societies) have institutional standing and the resources to participate. Active society membership and engagement matters more in 2026 than it did in 2024.

The Pendleton Question

Schedule Policy/Career raises a question that hasn't been seriously contested in American politics since the 19th century: whether the executive branch workforce should be staffed primarily by political loyalty or by professional merit. The Pendleton Civil Service Reform Act of 1883 settled that question for a century and a half. The 2026 rule reopens it.

For the research community, the question is narrower but no less consequential. Federal science funding is uniquely dependent on the technical judgment of program officers and the procedural integrity of merit review. Both have been protected for decades by the combination of civil service tenure, advisory council structures, and the apolitical norms of agencies like NSF and NIH. The new rule weakens the first leg of that three-legged stool.

The other two legs — advisory council structures and apolitical agency norms — remain in place but are now more exposed. Whether they hold depends on individual federal employees, on agency leadership, on the courts, and on a research community that has historically taken procedural integrity for granted.

Strategic Read

Grant seekers should not assume that the system has fundamentally changed yet. Most program officers are still in place. Merit review continues. NIH study sections are still scoring proposals on scientific merit. NSF is still funding the X-Labs initiative, the FINDERS FOUNDRY program, and the rest of its portfolio.

But the protective layer that made the traditional grant ecosystem stable is thinner now than it was three months ago. The right response is not catastrophizing — it is professional adaptation. Write things down. Diversify relationships. Build broader coalitions. Engage through professional societies. And track the pending litigation as carefully as you would track any major regulatory change that affects your work.

The Pendleton Act survived multiple administrations that disliked it because its alternative — the spoils system — produced visible dysfunction that voters eventually rejected. Whether the same dynamic plays out in 2026 and beyond is genuinely uncertain. Grant strategy in the meantime should assume both scenarios are possible and prepare for either.

Granted helps research organizations navigate federal funding in a shifting policy environment. To track program officer changes, agency-specific funding trends, and policy developments that affect your proposals, visit grantedai.com.